Gensia Pharmaceuticals
Executive Summary
Public offering of 2.8 mil. shares at $11 per share initiated on June 5. San Diego-based cardiovascular R&D firm originally registered 2.5 mil. shares for the initial offering ("The Pink Sheet" April 30, In Brief).